ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
GRI Bio Inc

GRI Bio Inc (GRI)

0.8875
0.0375
( 4.41% )
更新日時: 01:04:44

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.8875
買値
0.8797
売値
0.8964
出来高
159,027
0.86 日の範囲 0.92
0.3015 52 週間の範囲 115.57
前日終値
0.85
始値
0.8669
最終取引時間
01:05:20
平均取引量 (3 か月)
4,721,042
財務取引量
US$ 142,154
VWAP
0.893901

GRI 最新ニュース

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024

Proceeds from recent exercise of warrants estimated to extend cash runway into mid Q1 2025, including interim data readout from Phase 2a biomarker study of lead program, GRI-0621 for the treatment...

GRI Bio Announces Exercise of Warrants

LA JOLLA, CA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

Data suggest that NKT cells are activated in airways in Idiopathic Pulmonary Fibrosis (IPF) patients and inhibition of iNKT cell activity can treat bleomycin-induced pulmonary fibrosis Company...

GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis

LA JOLLA, CA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions

Company continues to advance an innovative pipeline of NKT cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, Sept. 30, 2024 (GLOBE...

GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia

MHRA and HREC authorization in Australia further expands and will potentially accelerate enrollment in ongoing U.S. and UK Phase 2a biomarker study evaluating lead program GRI-0621 for the...

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

Live video webcast on Wednesday, October 2nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0619-6.519907309880.94940.96190.795302020.88218455CS
40.4775116.4634146340.411.790.38119393791.06299386CS
120.397581.12244897960.491.790.301547210420.97469297CS
26-4.2475-82.71665043825.1356.23740.301525573941.20573288CS
52-110.1325-99.2005944875111.02115.570.301515952286.91960627CS
156-1200.3125-99.92611555111201.21213.030.3015105780512.4086701CS
260-1200.3125-99.92611555111201.21213.030.3015105780512.4086701CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MVSTMicrovast Holdings Inc
US$ 0.8025
(344.11%)
690.59M
NMHINatures Miracle Holding Inc
US$ 0.152891
(78.40%)
381.34M
BTCTBTC Digital Ltd
US$ 18.0388
(71.80%)
26.65M
KXINKaixin Holdings
US$ 4.8899
(67.46%)
41.14M
RKLBRocket Lab USA Inc
US$ 22.37
(52.59%)
61.39M
SYRSSyros Pharmaceuticals Inc
US$ 0.382
(-86.01%)
26.82M
GCTKGlucoTrack Inc
US$ 0.3799
(-75.79%)
3.22M
PETWag Group Company
US$ 0.1919
(-70.74%)
4.59M
VINOGaucho Group Holdings Inc
US$ 2.2805
(-48.75%)
167.05k
GLXGGalaxy Payroll Group Ltd
US$ 7.80
(-45.49%)
370.54k
MVSTMicrovast Holdings Inc
US$ 0.8025
(344.11%)
690.59M
NMHINatures Miracle Holding Inc
US$ 0.152891
(78.40%)
381.34M
AGRIAgriFORCE Growing Systems Ltd
US$ 0.051
(7.59%)
213.05M
ELABElevai Labs Inc
US$ 0.0196
(4.26%)
133.13M
XTIAXTI Aerospace Inc
US$ 0.056
(15.46%)
71.35M

GRI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock